New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban

Russell S. Roberson, Andrew D. Shaw

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban'. Together they form a unique fingerprint.